Adar1 Capital Management, LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $500 Billion distributed in 214 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $41.5B, Protagonist Therapeutics, Inc with a value of $39.4B, Ea Series Trust with a value of $35.9B, Zai Lab LTD with a value of $27.4B, and Immunovant, Inc. with a value of $19.5B.
Examining the 13F form we can see an decrease of $115B in the current position value, from $615B to 500B.
Adar1 Capital Management, LLC is based out at Austin, TX
Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$500 Billion
Healthcare: $303 Billion
ETFs: $17.1 Billion
Communication Services: $6.59 Billion
Utilities: $178 Million
Energy: $111 Million
Financial Services: $588,000
Stock Holdings Table Market Cap. of $50 Millions to $300 Millions
